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Background: African swine fever (ASF), a highly contagious fatal acute haemorrhagic viral disease of pigs currently
has no treatment or vaccination protocol and it threatens the pig industry worldwide. Recent outbreaks were
managed by farmers with ethnoveterinary preparations with various claims of effectiveness.
Results: We identified 35 compounds using GC-MS protocol and ASF virus (NIG 99) was significantly reduced by
some extracts and fractions of the plant. However, the plant was poorly extracted by water and cytotoxicity was
found to be a major problem with the use of the plant since its extracts also reduced the primary cells used in the
assay.
Conclusion: It is confirmed that the plant has antiviral potentials against ASF virus and farmers’ claims seem to
have certain degree of veracity, but finding the best means of exploring the potential of the plant while reducing
its cytotoxic effect in-vitro and in-vivo will be necessary.
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African swine fever (ASF), a highly contagious fatal
acute haemorrhagic viral disease of pigs results in major
economic losses and has substantial food security impli-
cations. The disease continues to devastate animal re-
sources (pigs) in parts of Sub-Saharan Africa and other
infected regions of the world [1-3]. Though studies are
on-going with regards to the preventative actions and
immunology of ASF virus (ASFV), to date, little success
has been made with regards to the development of pre-
ventive vaccine targeting the ASF virus or an effective
treatment [4]. This is due to the complex nature of the
virus, the acute fatality associated with it and the lack of* Correspondence: dayo.fasina@up.ac.za
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reproduction in any medium, provided the ordeep understanding of the immune response in ASF in-
fection [5].
Currently, in the event of an outbreak and its possible
spread within pig herds, the standard practice remains
the zoning, culling of the herd (stamping out) and pay-
ment of compensation to prevent epizootics [1], How-
ever, in most African countries, the lack of subsidies for
animal agriculture and poor implementation of compen-
sation policy has negatively impacted prompt reporting
and weakened transboundary animal disease control.
Alternative and complementary therapies have instead
been explored by resource-poor small-scale pig farmers
in West Africa, in an attempt to save their stock in
an outbreak situation. This has included unorthodox
methods, including the use of plants and other
ethnoveterinary preparations, with widely ranging claims
of effectiveness.
Medicinal plants have been used as remedies for
centuries and numerous ethnoveterinary assessments oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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evaluate their effectiveness [6-8]. The potency of plant
products used as antiviral agents are well-described
[9,10], and many plants have been used by farmers to
‘manage’ ASF. However, there are limited peer-reviewed
records of plants in general, and none specifically from
West Africa with evaluated activity against the ASF virus
[11-13]. One such plant fed to pigs has had unconfirmed
reports of reducing morbidity and mortality is Ancistro-
cladus uncinatus; and there have even been claims of
complete freedom from illness following oral adminis-
tration of Ancistrocladus uncinatus preparations. This
Liana plant species was previously described by Hutch
and Dalziel in South-Eastern Nigeria as reported by
Cheek [14] and a related plant has recently been de-
scribed by Thomas and Gereau [15]. While the geo-
graphical extent of A. uncinatus has been broadly
described, A. korupensis is specifically found in the trop-
ical swamp of the Korup National Park in Cameroun
and adjoining Cross River National Park in Nigeria. It
has a low population density, with approximately 13
plants per hectare [16].
Anti-malarial and anti-HIV properties of the
Ancistrocladus Liana plant have been reported [17-20].
In particular, certain naphthylisoquinoline alkaloids
(including korundamine, yaoundamine, korupensamine
have been shown to have a wide range of anti-HIV, anti-
malarial, fungicidal, larvicidal and moluscicidal biological
activities [18-20]. Michellamine B, another alkaloid
found in the plant, has demonstrated anti-HIV activity
through inhibition of viral reproduction, syncitium for-
mation, enzymatic and cell killing activities [19,21].
Although most viral life cycles consist of the following
stages: attachment to the host cell, release of viral gene
and possibly enzymes into the host cells, replication of
viral components using the host systems, assembly of
viral components into complete viral particles and the
release of viral particles to infect new cells [22]
Various antivirals have been developed and their ac-
tions range from identifying and disabling or interfering
with functional viral proteins and critical enzymes for
the virus, insertion of stop codons into the virus genetic
structures, interfering with the ability of the virus to
infilterate the target cells by binding the receptors and
attachment molecules, by blocking the binding site of
the virus or by the use of uncoating inhibitors amongst
others [23-25].
The antivirals for DNA viruses of which ASF is one,
can operate in one of the following ways:
 DNA synthesis inhibitors which can be Thymidine
kinase (TK) activated or not. The TK activated
antivirals are categorised as Purine analogues
(e.g. Guaning, Ganciclovir, Penclovir) or Pyrimidineanalogue (e.g. uridine, Trifluridine, Thymine,
Cytosine etc.). The non-TK activated antivirals
include the Foscarnet and others. In addition, there
are other antivirals that are not classified in this
group including the Tromantadine, Docosanol and
early protein affecting drug like Fomivirsen [23,25].
 Viral assembly disruption for example Rifampicin or
by inhibiting mRNA and protein synthesis, e.g.
Methisazone [26,27].
 Nucleoside analogue (e.g. Entecavir, Lamivudine),
nucleotide analogues (e.g. Adefovir, Tenofovir),
Nucleic acid inhibitors (e.g. Cidofovir), interferon-
cytokine stimulation (e.g. Interferon alpha 2b,) or with
unknown effect (e.g. Ribavirin, Moroxydine) [28,29].
Specifically, with regards to the ASFV, certain antivi-
rals have been assessed against the virus including
Chloroquine, which produced a time-dependent, fully-
reversible inhibition of both cytopathic effects and the
production of African swine fever virus (ASFV) in Vero
cells, but does not have any direct effect on the virus
nor on viral adsorption and internalization [30]. Choles-
terol reducing/removing drugs like Nystatin and Methyl-
β-Cyclodextrin have been proved to affect ASFV fusion
and subsequent replication since Cholesterol in the tar-
get membrane is needed for these functions to be com-
pleted [31,32]. These drugs directly impact on ASFV
entry and infection of cells.
Other drugs include Fluoroquinones a group of drugs
that has severely reduced the cytopathic effect of ASFV
infected Vero cells from early phase of infection and
prevented the detection of ASFV genome 7-days post
treatment. The drug also caused altered viral protein
possibly because of the putative ASFV-topoisomerase II
enzyme which was targeted and had its activity modified
[33]. Lauryl gallate has been tested and confirmed to
strongly inhibit African swine fever virus at non-toxic
concentration. ASFV production in Vero cells was com-
pletely prevented by the addition of the drug 1 hour before
virus adsorption; however in cells that were 5–8 hours
post infection, the drug had no effect. This same drug has
been shown to prevent both cellular and viral DNA syn-
thesis and viral transcription amongst other effect [34].
A dose-dependent viral-inhibition of African swine
fever virus has been reported in in-vitro assessment of
aqueous extracts of Pophyridium cruentum, Chlorella
autotrophica and Ellipsoidon sp. possibly due to sulpha-
ted polysaccharides [35]; and both resveratrol and
oxyresveratrol also worked in dose-dependent manners
in an in-vitro experiment causing a 98-100% reduction
in virus multiplication and viral titres; and inhibited viral
DNA replication. Though early viral protein synthesis
was observed in this experiment, late viral protein syn-
thesis and viral factory formation were blocked [13].
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significant reduction in the yield of ASFV and other
enveloped viruses possibly through its effect on viral
maturation and envelope formation in enveloped viruses
[36] and other such drugs that have been tested against
ASFV include but not limited to Chlorpromazine,
Dynamin, Clathrin and Cholera toxin [32,37].
In this study, we used a molecular biology approach to
evaluate the antiviral potentials of the plant A. uncinatus
in an in-vitro model of infection. Primary bone marrow
cells were infected with ASFV, treated with crude extracts
and fractions of A. uncinatus and their effect on the virus
were evaluated by real-time and conventional PCR.
Results
Phytochemical screening of leaves, stem and roots of
Ancistrocladus uncinatus
Leaf, root and stem portions of the pulverised plant re-
vealed the presence of alkaloids, cardiac glycosides and
steroids; saponins and flavonoids were only recovered
from the leaves while tannins were recovered from the
stem (Table 1). None of the plant portion contained
anthraquinones.
Determination of chemical compounds from A. uncinatus
The chemical compounds present in the different por-
tions of the plants identified by Gas chromatography–
mass spectrometry (GC-MS) are summarised in Table 2.
A total of 35 chemical compounds were identified with
N-Formylkorupensamin B being the most abundant in
the plant but concentrated more in the stem and leaves.
Certain compounds or their derivatives were present in
all parts of the plant while other compounds were recov-
ered only from certain parts of the plant (see Table 2,
and Additional files 1, 2 and 3).
Phytochemical constituents expressed on silica gel
Thin-layer-chromatography of fractions of Acetone
extracts in Ethyl acetate-methanol–water (EMW), Ben-
zene-Ethanol-Ammonia (BEA), and Chloroform-Ethyl
acetate-Formic acid (CEF) revealed that several active
principles exist in A. uncinatus and that these were best
expressed using BEA followed by CEF and then EMW.
It appears that the dominant principles in the plant were
non-polar/basic compounds but other chemicals with
varying polarities were also observed. The retention fac-
tors (Rf ) of the 10 clearly identified compounds in BEATable 1 Secondary metabolites found in the different stem b
Sample Saponin Alkaloids Cardiac glycosides
Leaves + + +
Roots - + +
Stem - + +were: 0.125; 0.175; 0.225; 0.263; 0.375; 0.538; 0.763;
0.850; 0.888 and 0.925 (see Figure 1b).
Cell viability and cytotoxicity assays
PBMC were confirmed viable since the cell culture
media gradually used up the phenol red in the medium
and changed the colour from orange to pale yellow over
a period of 7 days. The plates inoculated with ASF NIG/
99 virus showed distinct rosette formations around the
macrophages, an indication that the macrophages were
infected and haemadsorped with the pig red blood cells
in the medium. There was no visible reduction in cell
population when compared with cells inoculated for
diagnostic purposes and no rosette formations were vis-
ible in the plates inoculated with placebo (wash buffer
only). Complete or partial CPE was observed with con-
centrations of extract ≥5 mg/ml and for the pure extract
diluent (DMSO), however a 1:1000 dilution of the
diluent was non cytotoxic to the PBMC; there was no
apparent reduction in the macrophages population and
rosette formations developed normally compared to the
cells without the diluent (see Figure 2).
Antiviral assay of extract of A. uncinatus and its fractions
on African swine fever virus
Cells in the PBMC grew normally until approximately
96 hours post-infection following which some reductions
in rosette formations were observed. However, after
120 hours, marked reduction in the population of
Macrophages and CPE were observed indicating cell
deaths. Cell culture plates were read approximately
108–109 hours post-treatment. Noticeable reductions in
the quantity of rosette formations were observed in wells
treated with acetone, dichloromethane and methanol ex-
tracts and also in wells treated with hexane, methanol
and ethyl acetate fractions of acetone extract (Table 3).
Hexane and chloroform extracts and chloroform fraction
of Acetone extract showed minimal reduction in the
number of rosettes observed and counted, indicating
weak activities against ASFV (Table 3). The IC50 of the
Acetone extract was determined to be 17 μg.
Conventional PCR and real-time PCR (QPCR) assays
The PCR results confirmed the observed reduction in
rosette formation associated with reduced activities of
ASFV in-vitro in the presence of A. uncinatus extracts or
fractions. It will appear that Acetone, Dichloromethane,arks, leaves and roots of the A. uncinatus
Steroids Tannin Anthraquinones Flavonoids
+ - - +
+ - - -
+ + - -
Table 2 Compound expressed from the stem barks, leaves and roots of Ancistrocladus uncinatus
Compounds (source)* Molecular weight Retention time Retention index
1. n-Hexadecanoic acid (S, L) 256 25.43 1968
2. 7-Hexadecenoic acid (S) 268 27.24 1886
3. 9-Hexadecenoic acid (S, L, R) 254 27.76 1976
4. Octadecanoic acid (S, L) 284 28.06 2167
5. 1-Butanamine (S) 155 29.58 1103
6. 1,9-Nonanediol (S, R) 160 31.63 1401
7. Hexadecanoic acid (S, L, R) 330 31.94 2498
8. 3-Bromooctane (S) 192 32.37 1049
9. 1,3-Tetradecenal (S) 210 33.88 1591
10. 2-Quinolinecarboxylic acid (S) 421 38.31 2310
11. N,N’-Bis (p-Methoxybenxylidine) benzidine (S, L, R) 420 38.50 3749
12. N-Formylkorupensamin b (S, L) 407 39.28 3792
13. 4-Acetoxy-6′,7-dimethyl-5′,8′-dimethoxy-1,2′-binaphthalene-1′,4′,5,8-tetrone (S) 460 41.97 3926
14. 4-Pentadecyne (S) 242 42.69 1755
15. Stigmasterol,22,23-dihydro- (S) 414 44.14 2731
16. Bicyclo[3.1.0]hexan-3-ol (S) 154 45.35 1079
17. (Z)6,(Z)9-Pentadecadien-1-ol (L) 224 31.56 1771
18. 13-Oxabicyclo[10.1.0]tridecane (L) 182 33.88 1450
19. 7-Tetradecenal (L) 210 31.63 1609
20. Squalene (L, R) 410 35.58 2914
21. Silane (L) 442 35.78 2647
22. Beta-Tocopherol (L, R) 416 38.30 3036
23. 1H,3H-Furo[3,4-c]furan (L, R) 446 39.28 3243
24. Vitamin E (dl-alpha-Tocopherol) (L, R) 430 39.96 3149
25. Gamma-Sitosterol (L) 414 44.14 2731
26. 3,6-Octadien-1-ol,3,7-dimethyl-(Z)- (L) 154 45.37 1228
27. Cyclopentanol,3-methyl-2-(2-pentenyl)- (L) 168 46.09 1315
28. Decane, 1-chloro- Decyl Chloride (R) 176 44.13 1240
29. 3-Octadecyne (R) 250 45.34 1828
30. 2-Isopropyl-5-methylcyclohexymethanol (R) 170 42.68 1280
31. 9-Octadecenoic acid (R) 296 27.24 2085
32. 1-Fluorononane (R) 146 31.93 889
33. 3,8-Dibenzoyl-1-nitro-3,6,8-triazabicyclo[4.3.1]decane (R) 394 32.83 3353
34. Oxalic acid (R) 368 28.68 2606
35. 2,2,3,3,4,4,-Hexamethyltetrahydrofuran (R) 156 29.58 992
*Source of chemical compound as determined by gas chromatograph-mass spectrometry. S = stem, L = leaves and R = combination of residual leaves, stem and
root. A total of 35 compound and its derivatives were clearly isolated from the A. uncinatus stem, leaves and root.
See Additional files 1, 2 and 3 for details of the identified compounds.
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acetate fractions of Acetone extract were effective
against the ASFV as no 478 bp product was observed
(Figure 3, Lanes 1–9). However, Hexane extract and
Chloroform fraction displayed partial activities while
Chloroform extract showed no activity against ASFV.
The Ficus lutea plant control showed no activity
against ASFV (Figure 3, Lane 10–15). Both thepositive and negative controls passed the internal
quality control test required to accept the results
(see Figure 3).
No detectable level of ASF viral genome was observed
and quantitated from the QPCR since the fluorescent
measurement was not above the background signal for
any of the tested samples and no sigmoid-shaped curve
was observed.
a. Expression on CEF 
The TLC plates were shown here at 
b. Expression on BEA
a magnification of ×0.563
c. Expression on EMW
Figure 1 Expression fraction of Acetone extracts of A. uncinatus on TLC plates using three different expression methods. a-c are
chromatograms of Hexane (Hex), Di-Chloro Methane (DCM), Acetone (Ace) and methanolic (MeOH) extracts respectively. CEF = Chloroform-Ethyl
acetate-Formic acid; BEA = Benzene-Ethanol-Ammonia (BEA), and EMW= Ethyl acetate-methanol–water.
Fasina et al. BMC Veterinary Research 2013, 9:120 Page 5 of 11
http://www.biomedcentral.com/1746-6148/9/120Re-infectivity assay of extract of A. uncinatus
None of the cultures containing plant extracts (acet-
one, dichloromethane and methanol) and its fractions
(hexane, methanol and ethyl acetate fractions) showed
rosette formation 96 and 120 hours post-inoculation
indicating the lack of infectious virus in the inocu-
lum. However, the positive control wells (ASF NIG/99
virus) displayed characteristic growth patterns and
rosette formations that were comparable to the
expected standards. No growth was observed in the
negative controls (wash buffer). Observed cytotoxicity







































Figure 2 Dose-Effect Curves and Cytotoxicity patterns of A. uncinatusDiscussion
Certain important plant metabolites were found in abun-
dance in the analysed plant including the cardiac glyco-
sides, alkaloids and steroids. Cardiac glycoside has been
employed in the treatment of congestive heart failure
and cardiac arrhythmia. The ASF virus affects many
visceral organs including the heart and it has been sug-
gested previously that death following infection like
ASFV may be due to heart failure [38]. It is possible that
this plant positively influences cardiac outputs by in-
creasing the force of contraction through its effect on
the sodium-potassium pumps in the cell membrane [39].



















Table 3 Observation of activities of Ancistrocladus uncinatus extracts and fractions on haemadsorbing African swine
fever virus in-vitro 5-days post infection























1 +++ - + - ++ - - - - + -
0.5 +++ - ++ - ++ - - - - + -
0.25 +++ - ++ - ++ - - - - ++ -
0.125 +++ - +++ - +++ - - - + ++ -
0.0625 +++ - +++ + +++ - - + + +++ -
0.03125 +++ + +++ ++ +++ ++ + ++ ++ +++ -
0.015625 +++ ++ +++ ++ +++ ++ ++ ++ ++ +++ -
0.0078125 +++ +++ +++ +++ +++ +++ +++ +++ +++ +++ -
+++ = ≥50 rosettes were observed and counted in the well; ++ = 10–50 rosettes were observed and counted; + = ≤10 rosettes were observed and counted. - = no
rosette was observed. C = crude extract and F = fraction of extract. N.B. Rosette formation is an indication of virus infection of the macrophage cells in the
PBMC medium.
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the effect of the virus on the pig cells during in-vivo in-
fection. Additional research is required to determine the
particular metabolites or combinations of metabolites
that are responsible for the therapeutic claims ascribed
to this plant by the farmers. Galindo and colleagues [13]
and Fabregas et al., [35] has confirmed that chemical
compounds from natural plants performed as effectively
as those from synthetic sources.
Gas chromatography has been known to separate large
numbers of compounds in a single analysis and in
combination with mass spectrometry (GC-MS) usually
results in a highly selective and sensitive method of
chemical compound analysis in plants [40]. In this ana-
lysis, we used the method of GC-MS to identify at least
35 compounds from the plant A. uncinatus. These com-
pounds are consistent with those presented in previous
reports [17,18,21]. The range of activities of these com-
pounds extends from anti-tumour, febrifugal, virucidal,
anti-insulin, antibacterial, prostate treatment, vaccine





























f 0.50, the 
Figure 3 Agarose gel electrophoresis of conventional PCR assay usedWhile activities of this plant against HIV and certain
other human viruses have been evaluated [17,19], this is
the first report of its use against animal viruses specific-
ally. Though, the particular compound or interaction of
compounds that was responsible for this anti-ASF activ-
ity in the crude extracts and fractions used in this study
are not yet known, the in-vitro results support the claim
made by farmers of effectiveness of this plant in the
management of ASFV. Based on the re-infectivity assay,
some extracts and certain fractions of the plant have
good virucidal activities which can be positively explored
further. The cell culture system results were further
supported by conventional PCR and QPCR. Further test-
ing of each identified compound for individual and
combined ranges of biological activity against ASFV is
imperative.
It will also be important to carefully examine the cause
of cytotoxicity in this plant and devise ways of eliminat-
ing or reducing this effect in view of the substantial
therapeutic potential of this plant. Though the extracts





























to asses the effect of A. uncinatus on ASF virus.
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PBMC populations in the culture. Laird and Lisinge [45]
and Laird [46] have previously reported on the toxicity
associated with the A korupensis and this effect appeared
to be cumulative in this study using A. uncinatus. Simi-
lar report has been associated with increasing dose of
other drugs tested against the virus [13,33,34]. The anti-
viral activities of this plant are comparable to those of
Lauryl gallate and mulberry twigs which caused signifi-
cantly reduced viral titres and inhibition of viral DNA
replication at non-toxic doses [13,34].
It is possible that there is continuous intra-cytoplas-
mic absorption of A. uncinatus by the PBMC and the
post-96 hour levels of absorption were incompatible
with the survival of the macrophages due to this increas-
ing toxicity [44-46]. Thus, since the toxic dose level ap-
pears to be quite close to the anticipated effective
antiviral dose against ASFV, the plant likely has a narrow
therapeutic index in the field. It is possible that some of
the pigs that initially recovered following treatment with
A. uncinatus but later died may have succumbed to the
toxic effect of the plant. While this plant holds potential
for the treatment of certain viral infections in pigs,
including ASF, its cytotoxicity remains a concern that
will require extensive in-vivo assessment of acute and
chronic toxicity in live animals in order to validate the
effectiveness and therapeutic index of A. uncinatus in
the management of ASF in pigs.
The water extraction method poorly expressed the ac-
tive plant compounds and most of the expressed com-
pounds are basic to neutral. However, since water is an
important medium for drug administration, it will be
important to conduct additional studies to validate
methods by which water may be used in the administra-
tion of compounds and extracts from A. uncinatus.Conclusion
In conclusion, the farmers’ claims of the effectiveness of
the use of Ancistrocladus uncinatus in the management
of African swine fever seem to have a degree of empir-
ical support. Our experiment has provided evidence and
confirmed that the extracts and fractions of extract from
the plant have antiviral/virucidal activities against ASF
virus. It significantly reduced the viral titres in the PCR
assay and prevented virus replication to undetectable
level in the QPCR experiment as well as terminated the
infectiousness of the virus in-vitro. However, the cyto-
toxic effect of the plant will need to be overcome in
order to reduce the negative effect of the plant while still
harnessing its therapeutic potential. Further research on
the antiviral compounds and effect of the plant holds
potential for uncovering a novel antiviral compound and
should be explored further for this and other animalviruses for which treatment options are either limited or
non-existent.
Methods
Pre-screening of ethnoveterinary products used for ASF
management, plant collection and identification
Oral interviews were conducted with selected pig
farmers from different zones of Nigeria on the manage-
ment of African swine fever using ethnoveterinary prep-
arations during the past outbreaks of the disease, as part
of the national swine disease surveillance programme.
Many ethnoveterinary preparations were reported as
being used which were screened against published re-
sources to determine whether any preliminary antiviral
potential of the plants on the list had been confirmed
previously [6-8]. Ancistrocladus uncinatus was selected
on this basis, for further assessment against the African
swine fever virus.
The plant was identified at the Cross River National
Park, and sample specimens were collected for the prep-
aration of a herbarium. Authentication of the plant was
carried out by Mal. U. S. Gallah at the Herbarium of the
Ahmadu Bello University, Zaria, Nigeria using the pre-
scribed standards [14,15], and deposited in the herbar-
ium with the Voucher number 109413. The plant were
air-dried in the laboratory and separated into portions of
leaves, stems and roots. Each portion was pulverised
using Jika-Werke M20 blender (Jika-Werke, Staufen,
Germany) and stored in airtight cellophane bags at +4°C
until used.
Phytochemical screening of leaves, stem and roots of
Ancistrocladus uncinatus
Portions of the pulverised plant were screened for phyto-
chemical content and for certain secondary metabolites
including alkaloids, flavonoids, cardiac glycosides, sapo-
nins, tannins, anthraquinones, triterpenes and steroids
using standard methods [8,47-49].
Determination of chemical compounds from A. uncinatus
The chemical compounds present in the plant were de-
termined using the analysis of gas chromatography–
mass spectrometry (GC-MS) and the modified method
of Ivanov and Sandell [50]. Briefly described, 2 g por-
tions of leaves, stems and whole plant (stems, leaves and
roots) of A. uncinatus were each extracted with petrol-
eum ether and injected into column of the Shimadzu
Gas Chromatograph-Mass Spectrometer (GC-MS) QP
2010 PLUS (Shimadzu, Japan) and its software program-
me for analysis. Oven temperature was 60°C and injec-
tion temperature was 250°C, with a linear velocity of
46.3 cm/sec, a capillary column flow rate of 1.61 mL/
min and a pressure of 100.2 kPa. For the GC program-
me, the Ion source was set at 200°C and the interface
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MS analysis was done based on comparative retention
times, mass and peaks of the chemical compounds using
the NIST05.LIB as the reference database [52]. This
library enables the facilitation of comparison of gener-
ated spectra with the standards using Probability Based
Matching algorithms [52].
The (GC-MS) QP 2010 PLUS had also been pre-fitted
with a set of automated internal validity programmes for
the analysis, including the adjustment of retention time
function, scan measurement, quick and accurate com-
pound identification from chromatogram, search based
on mass spectra similarity and other quality assurance-
quality control functions [53].
Extractions and fractions from A. uncinatus
Individual distilled water, Acetone (Ace), Methanol
(MeOH), Hexane (Hex), Chloroform (Chloro) and DiCh-
loroMethane (DCM) extracts of each of the plant parts
were made using previously described methods [54].
Briefly, 10 g of the finely ground plant material was
soaked in 100 ml of each of the solvents in an Erlen-
meyer flasks. The contents were shaken on a Labotec
shaker M202 (Labotec Pty, South Africa) for 30 minutes
after which each extract was centrifuged at ≈ 2150 rpm
(4000 g, 12 cm radial distance) for 5 minutes in a
Rotofix 32A centrifuge (Hettich Zentrifugen, Tuttlingen,
Germany). The supernatants were filtered using a
125mmØ qualitative circles Whatman paper (no. 1) and
a glass funnel into pre-weighed glass vials. The whole
process was repeated thrice for each extract to exhaust-
ively extract the plant materials and the total volumes of
each filtrate were combined and solvent air-dried at
room temperature in a fume cupboard. The final prod-
ucts were weighed individually and stored at +4°C until
further use.
The different extracts were dissolved in Dimethyl sulfox-
ide (DMSO) to make a final 100 mg/ml stock solution
(ratio of 100 mg of extract to 1 ml DMSO). The quantity
of materials recovered, with the exception of the water ex-
traction process, was sufficient to enable further analysis.
Phytochemical analysis on silica gel
Portions (1 ml) of the acetone extract were dissolved in
9 ml of Hexane, Dichloromethane, Acetone and Metha-
nol to make a 10 mg/ml fractions of each solution. Ten
microlitres (10 μ) of each solution was spotted on a pre-
labelled aluminium-backed TLC silica plates (TLC Silica
Gel 60 F254, Merck, Darmstadt, Germany) with a
micropipette, 1 ml from the bottom of the plates
and thin-layer-chromatography was carried out in
Ethyl acetate-methanol–water [40:5.4:5] (EMW; polar/
neutral), Benzene-Ethanol-Ammonia [90:10:1] (BEA;
non-polar/basic), and Chloroform-Ethyl acetate-Formicacid [5:4:1] (CEF; intermediate polarity/acidic) using the
method of Kotze and Eloff [54]. Chromatograms were
developed in closed tanks in which the eluent wetted the
TLC plates. The final chromatograms were air-dried and
sprayed with Vanillin vapour (0.1 g)-Methanol (28 ml)-
H2SO4 (1 ml) solution. The Vanillin-sprayed plates were
then heated with dry heat for approximately 3 minutes
at 110°C for optimal colour development and detection
of the separated compounds.
Based on the expression on BEA, the retention factors
of the 10 clearly identified compounds were calculated
using the formula:
Rf ¼ Distance travelled by substanceDistance travelled by solvent
African swine fever virus and the primary bone marrow
culture
ASF NIG/99 (a haemadsorbing virus responsible for
major ASF outbreaks in Nigeria in 1999) was obtained
from the virus repository of the Transboundary Animal
Disease Programme (TADP) of the ARC-Onderstepoort
Veterinary Institute, South Africa. Primary bone marrow
culture (PBMC) adjusted to 1 × 107 cells/ml was pre-
pared in the 96-well flat bottom tissue culture plates
(Corning Costar®, Sigma Aldrich, Aston Manor, South
Africa) according to the Standard Operating Procedures
(R&D ASF 04–00) of TADP and incubated at 37°C for
48 hours at 5% CO2. The plates were observed under
the microscope for growth of macrophages, after which
the liquid contents of the plates were discarded 48 hours
post preparation and 100 μl of freshly prepared growth
medium was dispensed into each well of the plates. The
primary cells were then available for virus infection.
Additional file 4.
Cell viability and cytotoxicity assays
To assess for the viability of the PBM cells, consistency
of the plates were first checked for colour change (light
orange to pale yellow due to active metabolism in the
plates). Furthermore, each culture plate was inoculated
with 100 μl of ASF NIG/99 virus (7.0 log10 HAD50/ml.)
and the placebo (wash buffer), sealed and incubated in a
5% CO2 incubator at 37 C for 48 hours and checked for
haemadsorption activity (rosette formation) and cyto-
pathic effect (CPE). Cytotoxicity assay was done by in-
oculating the PBMC with different concentrations of
crude acetone extract of A. uncinatus (1000 mg/ml,
500 mg/ml, 100 mg/ml, 50 mg/ml, 25 mg/ml, 5 mg/ml
and 1 mg/ml), and the diluent (DMSO); and checking
daily for decreasing number of macrophages and rosette
formations. Based on the quantitated values obtained, a
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trations of the acetone extract (see Figure 2).
Antiviral assays of extract of A. uncinatus and its fractions
on African swine fever
Cell culture assay system
The modified methods of Vanden Berghe et al. [9] and
Ying-Wang et al., [10] were used when carrying out the
antiviral assessment of the plant.
Fresh PBMCs were prepared on the 96-well flat bottom
tissue culture plates as stated above and infected with
100 μl of the ASF NIG/99 virus (7.0 log10 HAD50/ml).
One in two (1:2) serial dilutions of the extracts (Acet-
one, Hexane, DochloroMethane, Methanol and Chloro-
form) and its fractions (Hexane, Methanol, Ethyl Acetate
and Chloroform) were prepared in ordinary 96-well
U-bottom plates to deliver 1 mg/ml up to 0.0078 mg/ml
in a 50 μl of each dilution. These dilutions were added
to rows in the ASF infected plates (see Table 4). Ficus
lutea extracts were used as plant controls. Only 50 μl of
the wash buffer was added to the positive controls and
no virus, extract or fraction was added to the negative
controls. The plates, prepared in triplicate were sealed,
and each of the experiments was performed twice. The
plates were incubated in a 5% CO2 incubator at 37 C for
48 hours and checked for haemadsorption activity (ros-
ette formation) and CPE. The 50% inhibitory concentra-
tion, IC50 (a dose that will reduce the activity of the




LN Conc > 50%ð Þ− ðsignal > 50%−50ð Þ=
signal > 50%−signal < 50%ð ÞLN
conc > 50%=conc < 50%ð ÞÞ

Using an automated excel worksheet developed by
Professors Maes and Cos of Antwerp University.Table 4 Set up of the test system for the antiviral assay













1 + * * * * *
0.5 + * * * * *
0.25 + * * * * *
0.125 + * * * * *
0.0625 + * * * * *
0.03125 + * * * * *
0.015625 + * * * * *
0.0078125 + * * * * *
(C) = crude extract; (F) = Fraction; DCM = Dichloro Methane; + = Positive control (ASF
Negative control (wash buffer).PCR and real-time PCR
Following a 7-day incubation period, the plates were
observed under the microscope and the 1 mg/ml test
systems of the A. uncinatus extracts and their fractions
were harvested and assessed by conventional PCR
targeting a 478 bp region of the p72 gene to determine if
there was any reduction in viral titres due to the effect
of the plant. Briefly, viral DNA was extracted from the
harvests using the supplier-prescribed High Pure PCR
Template Preparation Kit (Roche Diagnostic GmbH,
Mannheim, Germany) protocol. A set of forward and re-
verse primers: (p72U-GGCACAAGTTCGGACATGT
[sense] and p72D-TGTAACGCAGCACAG [anti-sense]
were used to amplify the C-terminal end of virus protein
(VP) 72, as previously described [55]. The resulting
products were sized by 1.5% agarose gel electrophoresis
against a 100 bp marker (Fermentas).
Real time/quantitative PCR (QPCR) was used to deter-
mine the residual quantity of the ASF viral genome that
was left in the extract/fraction treated samples or whether
viral replication subsists in the presence of extract. Briefly, a
set of forward (King-s (5′-CTGCTCATGGTATCAATCT
TATCGA-3′) and reverse King-a (5′-GATACCACAA
GATCRGCCGT-3′) primers, that amplify a conserved
250 bp region of VP72 were combined with a TaqMan
probe (5′-FAM-CCACGGGAGGAATACCAACCCAGTG
-TAMRA-3′) that detects the amplified product with the
label/reporter at the 5′ end [6-carboxy-fluorescein (FAM)
and a quencher at the 3′ end (6-carboxy-tetramethyl-
rhodamine (TAMRA)] [56]. The system was optimised at
95°C 3 min; 95°C 10s; 58°C 30s and 45 cycles with a cycle




Re-infectivity assay was performed to determine whether











* * * * -
* * * * -
* * * * -
* * * * -
* * * * -
* * * * -
* * * * -
* * * * -
NIG/99); * = Crude extract or fractions as stated in the table; - = Placebo/
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culture; briefly, 100 μl of the recently harvested virus-
extracts/fractions as well as the positive (ASF NIG/99
virus) and the negative (wash buffer) controls were filtered
using the 0.22 μ filter and inoculated again into freshly
prepared PBMC. The culture plates were incubated as de-
scribed above and microscopically inspected 72, 96 and
120 hours post-infection to determine the residual virus
infectivity following exposure to the extracts/fractions.
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